IPAD-DB ID | C00733 |
Name | PBT2 |
Category | Natural compounds |
2D Structure |
|
3D Structure | |
Molecular Formula | C 1 2 H 1 2 C l 2 N 2 O |
Molecular Weight | 271.14g/mol |
IUPAC Name | 5, 7-dichloro-2-[(dimethylamino)methyl]quinolin-8-ol |
InChI | InChI=1S/C12H12Cl2N2O/c1-16(2)6-7-3-4-8-9(13)5-10(14)12(17)11(8)15-7/h3-5, 17H, 6H2, 1-2H3 |
InChIKey | YZPOQCQXOSEMAZ-UHFFFAOYSA-N |
Canonical SMILES | CN(C)CC1=NC2=C(C=C1)C(=CC(=C2O)Cl)Cl |
PubChem CID | 10016012 |
DrugBank Accession Number | - |
CAS Registry Number | 747408-78-2, 1123760-88-2 |
Molecular Weight(Computed by SwissADME) | 271.14 |
Hac(Computed by SwissADME) | 17 |
Volume(Computed by ADMETlab 2.0) | 247.019 |
Density(Computed by ADMETlab 2.0) | 1.093 |
nRing(Computed by ADMETlab 2.0) | 2 |
MaxRing(Computed by ADMETlab 2.0) | 10 |
nHet(Computed by ADMETlab 2.0) | 5 |
fChar(Computed by ADMETlab 2.0) | 0 |
nRig(Computed by ADMETlab 2.0) | 11 |
Flexibility(Computed by ADMETlab 2.0) | 0.182 |
Stero Centers(Computed by ADMETlab 2.0) | 0 |
LogS(Computed by ADMETlab 2.0) | -2.963 |
LogD(Computed by ADMETlab 2.0) | 2.686 |
logP(Computed by ADMETlab 2.0) | 3.31 |
TPSA(Computed by SwissADME) | 36.36 Ų |
Hbond Acceptor(Computed by SwissADME) | 3 |
Hbond Donor(Computed by SwissADME) | 1 |
Rotatable Bonds(Computed by SwissADME) | 2 |
GI Absorption(Computed by SwissADME) | High |
BBB(blood-brain barrier) Permeant(Computed by SwissADME) | No |
P-gp Substrate(Computed by SwissADME) | No |
CYP1A2 Inhibitor(Computed by SwissADME) | Yes |
CYP2C19 Inhibitor(Computed by SwissADME) | No |
CYP2C9 Inhibitor(Computed by SwissADME) | Yes |
CYP2D6 Inhibitor(Computed by SwissADME) | No |
CYP3A4 Inhibitor(Computed by SwissADME) | Yes |
log Kp(Skin Permeation)(Computed by SwissADME) | -5.76 cm/s |
Lipinski(Computed by SwissADME) | Yes, 0 violation |
Ghose(Computed by SwissADME) | Yes |
Veber(Computed by SwissADME) | Yes |
Egan(Computed by SwissADME) | Yes |
Muegge(Computed by SwissADME) | Yes |
Bioavailability Score(Computed by SwissADME) | 0.55 |